Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?

Michalakis, Konstantinos G.

doi:10.2478/enr-2020-0018

Abstract

Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the metabolic health beneficial products of the adipose tissue. Nevertheless, adiponectin has been shown to exert some extra beneficial non metabolic actions, as well. Adiponectin levels can be related to reduced incidence of cancer in obese patients. Moreover, adiponectin has been shown to be implicated in the positive fertility outcomes of women. Some new studies have also indicated that adiponectin has a potential effect in the control of appetite, which raises a question, whether adiponectin could be accredited to be useful in the endocrine evaluation of obesity. Could these additional non-metabolic actions prove its helpfulness?

References

Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33, 547–594, 2012.10.1210/er.2011-1015
Search in Google Scholar Back to article
Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6, 55–68, 2007.10.1016/j.cmet.2007.06.003
Search in Google Scholar Back to article
Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, Mantzoros CS. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev 16, 308–313, 2007.10.1158/1055-9965.EPI-06-0621
Search in Google Scholar Back to article
Michalakis KG, Segars JH. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction. Fertil Steril 94, 1949–1957, 2010.10.1016/j.fertnstert.2010.05.010
Search in Google Scholar Back to article
Michalakis K. Adiponectin: The “unusual suspect” between insulin resistance and cancer? Prostate Cancer Prostatic Dis 22, 636–637, 2019.10.1038/s41391-019-0142-5
Search in Google Scholar Back to article
Nicolas S, Debayle D, Bechade C, Maroteaux L, Gay AS, Bayer P, Heurteaux C, Guyon A, Chabry J. Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression. Transl Psychiatry 8, 159, 2018.10.1038/s41398-018-0210-y
Search in Google Scholar Back to article
Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur J Endocrinol 182, G1–G32, 2020.10.1530/EJE-19-0893
Search in Google Scholar Back to article
Rifas-Shiman SL, Fleisch A, Hivert MF, Mantzoros C, Gillman MW, Oken E. First and second trimester gestational weight gains are most strongly associated with cord blood levels of hormones at delivery important for glycemic control and somatic growth. Metabolism 69, 112–119, 2017.10.1016/j.metabol.2017.01.019
Search in Google Scholar Back to article
Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS. Adiponectin acts in the brain to decrease body weight. Nat Med 10, 524–529, 2004.10.1038/nm1029
Search in Google Scholar Back to article
Seetho IW, Wilding JP. How to approach endocrine assessment in severe obesity? Clin Endocrinol (Oxf) 79, 163–167, 2013.10.1111/cen.12256
Search in Google Scholar Back to article
Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol 8, 93–100, 2016.10.1093/jmcb/mjw011
Search in Google Scholar Back to article

Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?

Abstract

Paradigm

My account